Controlling metastatic cancer: the role of phytochemicals in cell signaling
Language English Country Germany Media print-electronic
Document type Journal Article, Review
Grant support
VEGA 1/0136/19
Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
VEGA 1/0124/17
Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
PubMed
30903319
DOI
10.1007/s00432-019-02892-5
PII: 10.1007/s00432-019-02892-5
Knihovny.cz E-resources
- Keywords
- Chemoprevention, Metastatic cancer, Phytochemicals, Signaling pathways, Therapy,
- MeSH
- Biomarkers MeSH
- Chemoprevention MeSH
- Drug Resistance, Neoplasm drug effects MeSH
- Epithelial-Mesenchymal Transition drug effects MeSH
- Antineoplastic Agents, Phytogenic chemistry pharmacology therapeutic use MeSH
- Phytochemicals chemistry pharmacology therapeutic use MeSH
- Neoplasm Invasiveness MeSH
- Clinical Studies as Topic MeSH
- Humans MeSH
- Neoplasm Metastasis MeSH
- Tumor Microenvironment MeSH
- Neoplasms etiology metabolism pathology therapy MeSH
- Drug Evaluation, Preclinical MeSH
- Antineoplastic Combined Chemotherapy Protocols adverse effects therapeutic use MeSH
- Gene Expression Regulation, Neoplastic MeSH
- Signal Transduction drug effects MeSH
- Neoplasm Staging MeSH
- Treatment Outcome MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Biomarkers MeSH
- Antineoplastic Agents, Phytogenic MeSH
- Phytochemicals MeSH
PURPOSE: Cancer is a serious health issue and a leading cause of death worldwide. Most of the cancer patients (approximately 90%) do not die from the consequences of the primary tumor development, but due to a heavily treatable metastatic invasion. During the lengthy multistep process of carcinogenesis, there are a lot of opportunities available to reverse or slow down the tissue invasion or the process of tumor metastasis formation. RESULTS: Current research has brought many promising results from anti-metastatic experimental studies, and has shown that chemoprevention by natural or semisynthetic phytochemicals with plethora of biological activities could be one of the potentially effective options in the fight against this problem. However, there is a lack of clinical trials to confirm these findings. In this review, we focused on summarization and discussion of the general features of metastatic cancer, and recent preclinical and clinical studies dealing with anti-metastatic potential of various plant-derived compounds. CONCLUSIONS: Based on our findings, we can conclude and confirm our hypothesis that phytochemicals with pleiotropic anticancer effects can be very useful in retarding and/or reversing the metastasis process, and can also be used to prevent tissue invasion and metastases. But, further studies in this area are certainly necessary and desirable.
2nd Department of Surgery Faculty of Medicine Masaryk University Brno Czech Republic
Department of Immunology School of Medicine Keimyung University Daegu South Korea
Department of Internal Medicine Brothers of Mercy Hospital Polní 3 639 00 Brno Czech Republic
Institute for Health and Sport Victoria University Melbourne Australia
References provided by Crossref.org
Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care
The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis
Flavonoids in Cancer Metastasis